Results 11 to 20 of about 28,189 (202)

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate

open access: yesPharmaceutics, 2022
(1) Background: In their 60-year history, dimethyl fumarate and other salts of fumaric acid have been used for the treatment of psoriasis and other immune-mediated diseases for their immune-modulating properties.
Paolinelli Matteo   +7 more
doaj   +1 more source

Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study

open access: yesAnnals of Clinical and Translational Neurology, 2021
Objective Neuroinflammation is an important pathogenic mechanism in amyotrophic lateral sclerosis (ALS), with regulatory T cells (Tregs) mediating a slower rate of disease progression.
Steve Vucic   +6 more
doaj   +1 more source

Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways. [PDF]

open access: yes, 2020
Oxidative stress and chronic inflammation play critical roles in the pathogenesis of ulcerative colitis (UC) and inflammatory bowel diseases (IBD). A previous study has demonstrated that dimethyl fumarate (DMF) protects mice from dextran sulfate sodium ...
Farzaneh, Ted   +8 more
core   +2 more sources

Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis [PDF]

open access: yesFarmacia Hospitalaria, 2021
Objective: Dimethyl fumarate is a medication approved for the treatment of relapsing-remitting multiple sclerosis. The purpose of the study was to evaluate the safety and persistence of dimethyl fumarate in clinical practice and analyze the ...
Silvia Boullosa-Lale   +3 more
doaj   +1 more source

Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection. [PDF]

open access: yesPLoS ONE, 2015
Dimethyl fumarate is an immunomodulatory and neuroprotective drug, approved recently for the treatment of relapsing-remitting multiple sclerosis. In view of the limited therapeutic options for human acute and chronic polyneuritis, we used the animal ...
Kalliopi Pitarokoili   +4 more
doaj   +1 more source

The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway

open access: yesFrontiers in Medicine, 2022
Psoriasis vulgaris is a chronic inflammatory skin disease characterized by well-demarcated scaly plaques. Oxidative stress plays a crucial role in the psoriasis pathogenesis and is associated with the disease severity.
Elena Campione   +16 more
doaj   +1 more source

Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective. [PDF]

open access: yesPLoS ONE, 2016
The paper aimed to estimate the incremental cost-effectiveness ratio (ICER) at the public published price for delayed-release dimethyl fumarate versus relevant Multiple Sclerosis disease-modifying therapies available in France in June 2015.The economic ...
Julie Chevalier   +3 more
doaj   +1 more source

Drug-Repurposing Strategy for Dimethyl Fumarate

open access: yesPharmaceuticals, 2023
In the area of drug discovery, repurposing strategies represent an approach to discover new uses of approved drugs besides their original indications.
Salvatore Giunta   +8 more
doaj   +1 more source

A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models

open access: yesFrontiers in Molecular Biosciences, 2022
Friedreich’s ataxia (FA) is an inherited multisystemic neuro- and cardio-degenerative disorder. Seventy-four clinical trials are listed for FA (including past and present), but none are considered FDA/EMA-approved therapy.
Rosella Abeti   +7 more
doaj   +1 more source

Klotho pathways, myelination disorders, neurodegenerative diseases, and epigenetic drugs [PDF]

open access: yes, 2020
In this review we outline a rationale for identifying neuroprotectants aimed at inducing endogenous Klotho activity and expression, which is epigenetic action, by definition. Such an approach should promote remyelination and/or stimulate myelin repair by
Chen, Xiaohong   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy